AAAAAA
Results:
1-23
|
Results: 23
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Zipfel, PF
Brade, V
Citation: P. Kraiczy et al., Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates, INT IMMUNO, 1(3), 2001, pp. 393-401
Authors:
Schwertz, R
Rother, U
Anders, D
Gretz, N
Scharer, K
Kirschfink, M
Citation: R. Schwertz et al., Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: A long-term follow-up, PEDIAT A IM, 12(3), 2001, pp. 166-172
Authors:
Kurjane, N
Bruvere, R
Shitova, O
Romanova, T
Jaunalksne, I
Kirschfink, M
Sochnevs, A
Citation: N. Kurjane et al., Analysis of the immune status in Latvian Chernobyl clean-up workers with nononcological thyroid diseases, SC J IMMUN, 54(5), 2001, pp. 528-533
Authors:
Kirschfink, M
Citation: M. Kirschfink, Targeting complement in therapy, IMMUNOL REV, 180, 2001, pp. 177-189
Authors:
Tolksdorf, B
Frietsch, T
Quintel, M
Kirschfink, M
Becker, P
Lorentz, A
Citation: B. Tolksdorf et al., Humoral immune response to autologous blood transfusion in hip surgery: whole blood versus packed red cells and plasma, VOX SANGUIN, 81(3), 2001, pp. 180-186
Authors:
Frietsch, T
Fessler, H
Kirschfink, M
Nebe, T
Waschke, KF
Lorentz, A
Citation: T. Frietsch et al., Immune response to autologous transfusion in healthy volunteers: WB versuspacked RBCs and FFP. (vol 41, pg 470, 2001), TRANSFUSION, 41(6), 2001, pp. 851-851
Authors:
Frietsch, T
Fessler, H
Kirschfink, M
Nebe, T
Waschke, KF
Lorentz, A
Citation: T. Frietsch et al., Immune response to autologous transfusion in healthy volunteers: WE versuspacked RBCs and FFP, TRANSFUSION, 41(4), 2001, pp. 470-476
Authors:
Lehmann, TG
Koeppel, TA
Munch, S
Heger, M
Kirschfink, M
Klar, E
Post, S
Citation: Tg. Lehmann et al., Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia, MICROVASC R, 62(3), 2001, pp. 284-292
Authors:
Jurianz, K
Ziegler, S
Donin, N
Reiter, Y
Fishelson, Z
Kirschfink, M
Citation: K. Jurianz et al., K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement, INT J CANC, 93(6), 2001, pp. 848-854
Authors:
Kraiczy, P
Skerka, C
Kirschfink, M
Brade, V
Zipfel, PF
Citation: P. Kraiczy et al., Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H, EUR J IMMUN, 31(6), 2001, pp. 1674-1684
Authors:
Heller, A
Kunz, M
Samakas, A
Haase, M
Kirschfink, M
Koch, T
Citation: A. Heller et al., The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits, SHOCK, 13(4), 2000, pp. 285-290
Authors:
Keldenich, S
Kopp, R
Kirschfink, M
Klein, B
Henseler, A
Thelen, H
Oedekoven, B
Mottaghy, K
Citation: S. Keldenich et al., Application of a new dynamic flow model for investigating the biocompatibility of modified surfaces, ASAIO J, 46(1), 2000, pp. 134-141
Authors:
Klima, U
Kutschka, I
Warnecke, G
Kim, P
Struber, M
Kirschfink, M
Haverich, A
Citation: U. Klima et al., Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models, EUR J CAR-T, 18(3), 2000, pp. 321-327
Authors:
Nagy, G
Brozik, M
Varga, L
Fust, G
Kirschfink, M
Kiss, E
Gergely, P
Citation: G. Nagy et al., Usefulness of detection of complement activation products in evaluating SLE activity, LUPUS, 9(1), 2000, pp. 19-25
Authors:
Radke, A
Mottaghy, K
Goldmann, C
Khorram-Sefat, R
Kovacs, B
Janssen, A
Klosterhalfen, B
Hafemann, B
Pallua, N
Kirschfink, M
Citation: A. Radke et al., C1 inhibitor prevents capillary leakage after thermal trauma, CRIT CARE M, 28(9), 2000, pp. 3224-3232
Authors:
Lehmann, TG
Heger, M
Munch, S
Kirschfink, M
Klar, E
Citation: Tg. Lehmann et al., Complement inhibition by C1-Esterase-inhibitor reduces microcirculatory disturbances after warm hepatic ischemia., LANG ARCH S, 1999, pp. 629-633
Authors:
Binder, R
Kress, A
Kirschfink, M
Citation: R. Binder et al., Modulation of C5a-mediated effector functions of human polymorphonuclear leukocytes by tumor necrosis factor alpha and granulocyte macrophage colony-stimulating factor, EXP CLIN IM, 16(4), 1999, pp. 212-225
Authors:
Jurianz, K
Maslak, S
Garcia-Schuler, H
Fishelson, Z
Kirschfink, M
Citation: K. Jurianz et al., Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2, IMMUNOPHARM, 42(1-3), 1999, pp. 209-218
Authors:
Kirschfink, M
Nurnberger, W
Citation: M. Kirschfink et W. Nurnberger, C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application, MOL IMMUNOL, 36(4-5), 1999, pp. 225-232
Authors:
Binder, R
Kress, A
Kan, GZ
Herrmann, K
Kirschfink, M
Citation: R. Binder et al., Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst, MOL IMMUNOL, 36(13-14), 1999, pp. 885-892
Authors:
Jurianz, K
Ziegler, S
Garcia-Schuler, H
Kraus, S
Bohana-Kashtan, O
Fishelson, Z
Kirschfink, M
Citation: K. Jurianz et al., Complement resistance of tumor cells: Basal and induced mechanisms, MOL IMMUNOL, 36(13-14), 1999, pp. 929-939
Authors:
Kerr, SR
Dalmasso, AP
Apasova, EV
Chen, SS
Kirschfink, M
Matas, AJ
Citation: Sr. Kerr et al., Mouse-to-rabbit xenotransplantation - A new small animal model of hyperacute rejection mediated by the classical complement pathway, TRANSPLANT, 67(3), 1999, pp. 360-365
Authors:
Protzer, U
Nassal, M
Chiang, PW
Kirschfink, M
Schaller, H
Citation: U. Protzer et al., Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection, P NAS US, 96(19), 1999, pp. 10818-10823
Risultati:
1-23
|